MedPath

ACTEMRA

ACTEMRA

Approved
DIN Number

02424770

Drug Class

Human

Market Date

May 30, 2014

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02424770
AIG Number0152713002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AC07 TOCILIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

TOCILIZUMABActive
Strength: 162 MG / 0.9 ML
Monograph: TOCILIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.